We are live on ! Find out more
CL

CIM LLC Portfolio holdings

AUM $773M
1-Year Est. Return 28.11%
This Fund
S&P 500
This Quarter Est. Return
+8.23%
1 Year Est. Return
+28.11%
3 Year Est. Return
+108.42%
5 Year Est. Return
+152.34%
10 Year Est. Return
+801.11%
AUM
$504M
AUM Growth
+$29.7M
Cap. Flow
-$5.24M
Cap. Flow %
-1.04%
Top 10 Hldgs %
33.18%
Holding
162
New
13
Increased
40
Reduced
90
Closed
13

Sector Composition

Rank Sector Weight
1 Miscellaneous 20.69%
2 Consumer Discretionary 17.79%
3 Technology 14.03%
4 Financials 13.96%
5 Healthcare 13.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CLFD icon
151
Clearfield
CLFD
$419M
-2,794
Closed -$332K
DVY icon
152
iShares Select Dividend ETF
DVY
$22.9B
-3,071
Closed -$364K
EXEL icon
153
Exelixis
EXEL
$14.2B
-46,590
Closed -$783K
GLOB icon
154
Globant
GLOB
$1.55B
-5,184
Closed -$978K
IIPR icon
155
Innovative Industrial Properties
IIPR
$1.55B
-2,485
Closed -$277K
IVE icon
156
iShares S&P 500 Value ETF
IVE
$49.6B
-2,486
Closed -$357K
NNDM
157
Nano Dimension
NNDM
$327M
-11,500
Closed -$28K
NVR icon
158
NVR
NVR
$16.5B
-245
Closed -$1.04M
PFE icon
159
Pfizer
PFE
$158B
-32,281
Closed -$1.55M
RGEN icon
160
Repligen
RGEN
$10.2B
-4,261
Closed -$791K
TSLA icon
161
Tesla
TSLA
$1.48T
-3,164
Closed -$721K
URG
162
Ur-Energy
URG
$489M
-17,000
Closed -$22K

Similar funds

CIM LLC's Q4 2022 Portfolio in Review

As of Q4 2022, CIM LLC held 162 positions worth $504M, up 6.3% from $474M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

CIM LLC's Q4 2022 filing shows 13 new, 40 increased, 90 reduced and 13 closed positions. Its largest new stake was Lennar Class A: 32,822 shares worth $3.2M. The largest sale was Novo Nordisk, an estimated $4.94M.

By sector, the portfolio is most concentrated in Miscellaneous at 21% of assets, down from 22% a quarter earlier, followed by Consumer Discretionary and Technology.

  • CIM LLC's largest Q4 2022 buy was Lennar Class A: 32,822 shares worth $3.2M.
  • CIM LLC added most to Intuit in Q4 2022, an estimated $3.23M increase.
  • CIM LLC's biggest Q4 2022 reduction was Novo Nordisk, cutting an estimated $4.94M.
  • CIM LLC fully exited Pfizer in Q4 2022, selling an estimated $1.55M.
  • CIM LLC's ten largest holdings make up 33% of its $504M portfolio in Q4 2022.
  • CIM LLC opened 13 new positions and closed 13 in Q4 2022.
  • CIM LLC's portfolio value rose 6.3% quarter-over-quarter to $504M.

Based on CIM LLC's 13F filing for Q4 2022, filed 10 Feb 2023.